Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

FDA clears new catheter for peripheral blood clots
The new-look catheter came out of a medical device incubator started by entrepreneur Eitan Konstantino, PhD, who has years of experience in the vascular space.
Boston Scientific recalls premixed embolic agent after two deaths
There have been a total of 11 incidents so far, including seven injuries and two deaths. Boston Scientific said the agent can still be used if operators follow specific instructions during lower GI bleed embolization procedures.
Anemia may help explain why women are more likely to die during heart bypass surgery
Finding new ways to avoid intraoperative anemia could go a long way toward improving outcomes for female CABG patients. The full analysis, based on more than 1.4 million patients, was published in the Journal of the American College of Cardiology.
FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices
The anticoagulant was originally developed for patients with end-stage renal disease and atrial fibrillation.
FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary
The recall is due to ongoing concerns about the devices breaking. Three patients have been injured as a result of this issue.

FDA grants fast track designation to Bayer’s new drug for preventing stroke in AFib patients

The new drug, asundexian, is currently the subject of two multicenter Phase III studies—the OCEANIC-AF trial and OCEANIC-STROKE trial—focused on its safety and efficacy.

May 16, 2023

Healthcare M&A, mergers and acquisitions business deal.

Report: Medtronic, Johnson & Johnson consider Shockwave Medical acquisition after Boston Scientific talks stall

Shockwave Medical has already had a busy, successful 2023—what could be next for the IVL specialists?

May 11, 2023

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD trial prsented at SCAI 2022. #DisruptPAD, #DisruptCAD, #SCAI #SCAI22 #SCAI2022

Boston Scientific’s deal to acquire Shockwave Medical reportedly hits a snag

Talks between the two companies have reached a standstill, according to a new report. The rumor appears to have impacted the stock prices of both Boston Scientific and Shockwave Medical.

May 8, 2023

Fewer stress tests, more high-risk procedures: How working at a hospital influences cardiologists

Cardiologists employed by a hospital appear to be more likely to pursue cardiac catheterization or angioplasty than independent cardiologists.

May 4, 2023

Abbott completes $850M acquisition of Minnesota-based Cardiovascular Systems

The deal represents a significant addition to Abbott’s cardiovascular portfolio.

April 28, 2023

Private equity-backed cardiology group partners with additional healthcare investment firm.

Florida-based network of outpatient vascular centers partners with 2 private equity investment firms

American Vascular Associates believes the new investments from Petra Capital Partners and Canopy Capital Partners should help it keep up with the rising demand of outpatient treatment options.

April 27, 2023

Medtronic’s Endurant stent graft system for EVAR linked to strong 10-year outcomes

Researchers examined 10-year follow-up data from approximately 400 EVAR patients, sharing their findings at the 2023 Charing Cross Symposium in London.

April 27, 2023

HeartFlow announces US launch of AI-powered solution for evaluating coronary arteries

The AI-powered tool gained FDA clearance back in October 2022.

April 18, 2023

Vascular & Endovascular

FDA clears new catheter for peripheral blood clots

Boston Scientific recalls premixed embolic agent after two deaths

Anemia may help explain why women are more likely to die during heart bypass surgery

FDA grants anticoagulant its orphan drug designation for treating patients with implanted devices

FDA announces new recall of neurovascular catheters built by Johnson & Johnson subsidiary